BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31243081)

  • 1. Optimizing Systems for Cas9 Expression in Toxoplasma gondii.
    Markus BM; Bell GW; Lorenzi HA; Lourido S
    mSphere; 2019 Jun; 4(3):. PubMed ID: 31243081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii.
    Markus BM; Boydston EA; Lourido S
    mSphere; 2021 Oct; 6(5):e0047421. PubMed ID: 34643425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of CRISPR/Cas9 for Efficient Genome Editing in Toxoplasma gondii.
    Shen B; Brown K; Long S; Sibley LD
    Methods Mol Biol; 2017; 1498():79-103. PubMed ID: 27709570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 and genetic screens in malaria parasites: small genomes, big impact.
    Ishizaki T; Hernandez S; Paoletta MS; Sanderson T; Bushell ESC
    Biochem Soc Trans; 2022 Jun; 50(3):1069-1079. PubMed ID: 35621119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting back malaria: CRISPR/Cas9 genome editing of Plasmodium.
    Lee MCS; Lindner SE; Lopez-Rubio JJ; Llinás M
    Brief Funct Genomics; 2019 Sep; 18(5):281-289. PubMed ID: 31365053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New and emerging uses of CRISPR/Cas9 to genetically manipulate apicomplexan parasites.
    Di Cristina M; Carruthers VB
    Parasitology; 2018 Aug; 145(9):1119-1126. PubMed ID: 29463318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii.
    Shen B; Powell RH; Behnke MS
    J Vis Exp; 2017 Jun; (124):. PubMed ID: 28671645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology.
    Bai B; Myklebust JH; Wälchli S
    Methods Mol Biol; 2020; 2115():445-454. PubMed ID: 32006416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-Mediated Generation of Tetracycline Repressor-Based Inducible Knockdown in Toxoplasma gondii.
    Jacot D; Soldati-Favre D
    Methods Mol Biol; 2020; 2071():125-141. PubMed ID: 31758450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple CRISPR-Cas9 Genome Editing in Saccharomyces cerevisiae.
    Laughery MF; Wyrick JJ
    Curr Protoc Mol Biol; 2019 Dec; 129(1):e110. PubMed ID: 31763795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9.
    Shen B; Brown KM; Lee TD; Sibley LD
    mBio; 2014 May; 5(3):e01114-14. PubMed ID: 24825012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.
    Uranga M; Aragonés V; Selma S; Vázquez-Vilar M; Orzáez D; Daròs JA
    Plant J; 2021 Apr; 106(2):555-565. PubMed ID: 33484202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
    Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9-based genome-wide screening of Toxoplasma gondii.
    Sidik SM; Huet D; Lourido S
    Nat Protoc; 2018 Jan; 13(1):307-323. PubMed ID: 29323662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Noncoding RNA Domains to Genomic Loci with CRISPR-Display: Guidelines for Designing, Building, and Testing sgRNA-ncRNA Expression Constructs.
    Shechner DM
    Methods Mol Biol; 2021; 2162():115-152. PubMed ID: 32926381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
    Shin HR; Kweon J; Kim Y
    Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High efficiency CRISPR/Cas9 genome editing system with an eliminable episomal sgRNA plasmid in Pichia pastoris.
    Yang Y; Liu G; Chen X; Liu M; Zhan C; Liu X; Bai Z
    Enzyme Microb Technol; 2020 Aug; 138():109556. PubMed ID: 32527526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.